RAUL
ORTIZ QUESADA
Investigador en el periodo 2015-2018
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (10)
2022
-
Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines
Neurotoxicity Research, Vol. 40, Núm. 6, pp. 1645-1652
2019
-
O6-methylguanine-DNA methyltransferase promoter methylation in patients with rectal adenocarcinoma after chemoradiotherapy treatment: Clinical implications
Balkan Medical Journal, Vol. 36, Núm. 5, pp. 283-286
2018
-
Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review
Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578
-
Proteomic biomarkers in body fluids associated with pancreatic cancer
Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587
2017
-
Gastrointestinal stromal tumours: An actualized overview
European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112
2015
-
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(Butylcyanoacrylate) nanoparticles
International Journal of Nanomedicine, Vol. 10, pp. 1291-1306
2014
-
Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers
Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720
2013
-
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance
Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541
2012
-
5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
International Journal of Nanomedicine, Vol. 7, pp. 95-107
-
Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure
International Journal of Molecular Sciences, Vol. 13, Núm. 12, pp. 16624-16635